SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-038950
Filing Date
2019-06-25
Accepted
2019-06-25 16:49:10
Documents
2
Period of Report
2019-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1596
2 POA DOCUMENT poa.txt EX-24.3_861969 4254
  Complete submission text file 0001209191-19-038950.txt   7361
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Issuer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UNUM THERAPEUTICS INC. 200 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address
Osborne Matthew Scott (Reporting) CIK: 0001780543 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38443 | Film No.: 19919127